Table 4

Comparisons between UKPDS-CHD (CHD=coronary heart disease) (A) and Framingham risk scores (B) with and without the addition of microalbuminuria (no/yes), diabetic retinopathy (DR) (no/yes), DR+microalbuminuria, moderate–severe DR, and moderate–severe DR+microalbuminuria in assessing the presence of the combined endpoint

A
	ROC area	SE	95% CI	P value
UKPDS-CHD	0.658	0.044	0.58 to 0.75
UKPDS-CHD+microalbuminuria	0.683	0.044	0.60 to 0.77	0.191
UKPDS-CHD+DR	0.687	0.045	0.60 to 0.77	0.198
UKPDS-CHD+microalbuminuria and DR	0.701	0.044	0.62 to 0.79	0.074
UKPDS-CHD+moderate–severe DR	0.729	0.041	0.65 to 0.818	0.001
UKPDS-CHD+microalbuminuria and moderate–severe DR	0.733	0.042	0.65 to 0.82	0.008

B
Framingham	0.649	0.045	0.56 to 0.78
Framingham+microalbuminuria	0.66	0.045	0.57 to 0.75	0.52
Framingham+DR	0.678	0.046	0.59 to 0.77	0.269
Framingham+microalbuminuria and DR	0.683	0.045	0.60 to 0.77	0.223
Framingham+moderate–severe DR	0.717	0.042	0.67 to 0.83	0.007
Framingham+microalbuminuria and moderate–severe DR	0.714	0.043	0.63 to 0.80	0.034

UKPDS, United Kingdom Prospective Diabetes Study.